The association between inflammatory bowel disease (IBD)and primary sclerosing cholangitis should be considered a distinct clinical entity. This association involves genetic abnormalities, epidemiological factors (more common in men, with no a geographical pattern)and, commonly, subclinical inflammation, predominance of the right colon (endoscopic and histological), backwash ileitis and rectal sparing. Furthermore, there is an increased risk of colorectal cancer and cholangiocarcinoma. The aim of this review is to show how IBD influences the progression of this entity, transplantation requirements and recurrence. We also discuss the current evidence on the use of biological therapy in this group of patients.
|Translated title of the contribution||Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation|
|Number of pages||10|
|Journal||Gastroenterologia y Hepatologia|
|State||Published - May 2019|
Bibliographical notePublisher Copyright:
© 2019 Elsevier España, S.L.U.